These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1495 related articles for article (PubMed ID: 34185046)

  • 21. A population-based assessment of myocarditis after messenger RNA COVID-19 booster vaccination among adult recipients.
    Naveed Z; Li J; Naus M; Velásquez García HA; Wilton J; Janjua NZ;
    Int J Infect Dis; 2023 Jun; 131():75-78. PubMed ID: 36967038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older.
    Simone A; Herald J; Chen A; Gulati N; Shen AY; Lewin B; Lee MS
    JAMA Intern Med; 2021 Dec; 181(12):1668-1670. PubMed ID: 34605853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.
    Abraham N; Spruin S; Rossi T; Fireman B; Zafack J; Blaser C; Shaw A; Hutchings K; Ogunnaike-Cooke S
    Vaccine; 2022 Jul; 40(32):4663-4671. PubMed ID: 35750537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
    Klein NP; Lewis N; Goddard K; Fireman B; Zerbo O; Hanson KE; Donahue JG; Kharbanda EO; Naleway A; Nelson JC; Xu S; Yih WK; Glanz JM; Williams JTB; Hambidge SJ; Lewin BJ; Shimabukuro TT; DeStefano F; Weintraub ES
    JAMA; 2021 Oct; 326(14):1390-1399. PubMed ID: 34477808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute cardiac side effects after COVID-19 mRNA vaccination: a case series.
    Freise NF; Kivel M; Grebe O; Meyer C; Wafaisade B; Peiper M; Zeus T; Schmidt J; Neuwahl J; Jazmati D; Luedde T; Bölke E; Feldt T; Jensen BEO; Bode J; Keitel V; Haussmann J; Tamaskovics B; Budach W; Fischer JC; Knoefel WT; Schneider M; Gerber PA; Pedoto A; Häussinger D; van Griensven M; Rezazadeh A; Flaig Y; Kirchner J; Antoch G; Schelzig H; Matuschek C
    Eur J Med Res; 2022 Jun; 27(1):80. PubMed ID: 35655235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.
    Block JP; Boehmer TK; Forrest CB; Carton TW; Lee GM; Ajani UA; Christakis DA; Cowell LG; Draper C; Ghildayal N; Harris AM; Kappelman MD; Ko JY; Mayer KH; Nagavedu K; Oster ME; Paranjape A; Puro J; Ritchey MD; Shay DK; Thacker D; Gundlapalli AV
    MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(14):517-523. PubMed ID: 35389977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series.
    Fazlollahi A; Zahmatyar M; Noori M; Nejadghaderi SA; Sullman MJM; Shekarriz-Foumani R; Kolahi AA; Singh K; Safiri S
    Rev Med Virol; 2022 Jul; 32(4):e2318. PubMed ID: 34921468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada.
    Buchan SA; Alley S; Seo CY; Johnson C; Kwong JC; Nasreen S; Thampi N; Lu D; Harris TM; Calzavara A; Wilson SE
    JAMA Pediatr; 2023 Apr; 177(4):410-418. PubMed ID: 36848096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study.
    Naveed Z; Li J; Spencer M; Wilton J; Naus M; García HAV; Otterstatter M; Janjua NZ
    CMAJ; 2022 Nov; 194(45):E1529-E1536. PubMed ID: 36410749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination-Associated Myocarditis and Myocardial Injury.
    Altman NL; Berning AA; Mann SC; Quaife RA; Gill EA; Auerbach SR; Campbell TB; Bristow MR
    Circ Res; 2023 May; 132(10):1338-1357. PubMed ID: 37167355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocarditis Following COVID-19 Vaccination: A Systematic Review (October 2020-October 2021).
    Lee ASY; Balakrishnan IDD; Khoo CY; Ng CT; Loh JKX; Chan LL; Teo LLY; Sim DKL
    Heart Lung Circ; 2022 Jun; 31(6):757-765. PubMed ID: 35227610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute Myocarditis in a Patient Following mRNA-1273 SARS-CoV-2 Vaccination.
    Kawakami T; Yahagi K; Sekiguchi M; Ishizawa T; Nonaka H; Setoguchi N; Watanabe Y; Nakase M; Horiuchi Y; Asami M; Yuzawa H; Komiyama K; Tanaka J; Aoki J; Tanabe K
    Intern Med; 2022 May; 61(9):1371-1374. PubMed ID: 35249920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial Injury Pattern at MRI in COVID-19 Vaccine-Associated Myocarditis.
    Fronza M; Thavendiranathan P; Chan V; Karur GR; Udell JA; Wald RM; Hong R; Hanneman K
    Radiology; 2022 Sep; 304(3):553-562. PubMed ID: 35166587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute myocarditis following a third dose of COVID-19 mRNA vaccination in adults.
    Simone A; Herald J; Chen A; Nayak R; Shen YA; Lee MS
    Int J Cardiol; 2022 Oct; 365():41-43. PubMed ID: 35870635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination-A nationwide study.
    Su WJ; Liu YL; Chang CH; Lin YC; Huang WI; Wu LC; Chen SF; Lin YS; Hsieh YL; Yang CA; Lin CH; Chan KA; Lee PI; Chuang JH; Yang CH
    J Microbiol Immunol Infect; 2023 Jun; 56(3):558-565. PubMed ID: 36804307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 Years.
    Hu M; Shoaibi A; Feng Y; Lloyd PC; Wong HL; Smith ER; Amend KL; Kline A; Beachler DC; Gruber JF; Mitra M; Seeger JD; Harris C; Secora A; Obidi J; Wang J; Song J; McMahill-Walraven CN; Reich C; McEvoy R; Do R; Chillarige Y; Clifford R; Cooper DD; Forshee RA; Anderson SA
    JAMA Netw Open; 2024 Apr; 7(4):e248192. PubMed ID: 38656578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Booster vaccination with SARS-CoV-2 mRNA vaccines and myocarditis in adolescents and young adults: a Nordic cohort study.
    Hviid A; Nieminen TA; Pihlström N; Gunnes N; Dahl J; Karlstad Ø; Gulseth HL; Sundström A; Husby A; Hansen JV; Ljung R; Hovi P
    Eur Heart J; 2024 Apr; 45(15):1327-1335. PubMed ID: 38365960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
    Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine.
    Park J; Brekke DR; Bratincsak A
    Cardiol Young; 2022 Jan; 32(1):146-149. PubMed ID: 34180390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study.
    Kracalik I; Oster ME; Broder KR; Cortese MM; Glover M; Shields K; Creech CB; Romanson B; Novosad S; Soslow J; Walter EB; Marquez P; Dendy JM; Woo J; Valderrama AL; Ramirez-Cardenas A; Assefa A; Campbell MJ; Su JR; Magill SS; Shay DK; Shimabukuro TT; Basavaraju SV;
    Lancet Child Adolesc Health; 2022 Nov; 6(11):788-798. PubMed ID: 36152650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 75.